POOLBEG PHARMA PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.55 GBX | +0.74% |
|
+3.43% | +49.71% |
| May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
| May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Chart calendar Poolbeg Pharma PLC
3859d87121f72dc659ded006eb0.Gv8dbqfU_4s-vYEayvsEugAzn3sEqj69UpU5qekUopc.VqZ4KfS9zuVojvgipLht625CqzVv9Q_HY_JP8LptwflNqWcU0pu780_51A~162d2949fec504dffc449781fcb10c69
Upcoming events on Poolbeg Pharma PLC
Past events on Poolbeg Pharma PLC
| 2024-06-02 | BIO International Convention |
| 2024-04-30 01:00 pm | Business Update Call |
| 2024-04-30 02:00 am | Q4 2023 Earnings Release |
| 2024-01-17 01:00 pm | Business Update Call |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting |
| 2023-12-01 05:00 am | International Immunology Congress |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-10 07:30 am | Investor Meeting |
| 2023-11-06 09:00 am | Investor Meeting |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-24 | ShareSoc Investor Webinar |
| 2023-10-16 | World Vaccine Congress |
| 2023-09-20 07:30 am | Master Investor Sector Focus Healthcare Conference |
| 2023-09-13 02:00 am | Q2 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-13 | BioEquity Europe Conference |
| 2023-05-11 07:00 am | Annual General Meeting |
| 2023-05-02 | LSX World Congress |
| 2023-04-24 | BioTrinity Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -4,96 -6,15 19.35% | -4,66 -5,74 18.75% | -6,50 |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -4,99 -6,18 19.34% | -4,69 -5,84 19.76% | -6,53 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -4,78 -6,60 27.62% | -4,51 -5,60 19.55% | -6,38 |
|
Net income Million GBP | Released Forecast Spread | -2,34 | -4,69 -6,60 29% | -3,93 -5,60 29.8% | -6,38 |
|
EPS GBP | Released Forecast Spread | -0,01 | -0,01 -0,01 24.68% | -0,01 -0,01 28.18% | -0,01 |
| Announcement Date | 02/03/22 | 30/03/23 | 30/04/24 | - |
More events
Past sector events for Poolbeg Pharma PLC
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- POLB Stock
- Calendar Poolbeg Pharma PLC
